Targeting Met and Notch in the Lfng-deficient, Met-amplified triple-negative breast cancer

References

• Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience?. Nat Rev Clin Oncol 2010; 7:683 - 92; http://dx.doi.org/10.1038/nrclinonc.2010.154; PMID: 20877296
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010; 363:1938 - 48; PMID: 21067385
   PubMed Web of Science ®Google Scholar
• Hudis CA, Gianni L. Triple-negative breast cancer: an unmet medical need. Oncologist 2011; 16:Suppl 1 1 - 11; PMID: 21278435
   PubMed Web of Science ®Google Scholar
• Podo F, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, et al, FEMME Consortium. Triple-negative breast cancer: present challenges and new perspectives. Mol Oncol 2010; 4:209 - 29; PMID: 20537966
   PubMed Web of Science ®Google Scholar
• Perou CM. Molecular stratification of triple-negative breast cancers. Oncologist 2011; 16:Suppl 1 61 - 70; http://dx.doi.org/10.1634/theoncologist.2011-S1-61; PMID: 21278442
   PubMed Web of Science ®Google Scholar
• Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008; 14:1368 - 76; http://dx.doi.org/10.1158/1078-0432.CCR-07-1658; PMID: 18316557
   PubMed Web of Science ®Google Scholar
• Perou CM, Børresen-Dale AL. Systems biology and genomics of breast cancer. Cold Spring Harb Perspect Biol 2011; 3:a003292; http://dx.doi.org/10.1101/cshperspect.a003293; PMID: 21047916
   PubMedGoogle Scholar
• Creighton CJ, Chang JC, Rosen JM. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 2010; 15:253 - 60; http://dx.doi.org/10.1007/s10911-010-9173-1; PMID: 20354771
   PubMed Web of Science ®Google Scholar
• Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009; 69:4116 - 24; http://dx.doi.org/10.1158/0008-5472.CAN-08-3441; PMID: 19435916
   PubMed Web of Science ®Google Scholar
• Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704 - 15; http://dx.doi.org/10.1016/j.cell.2008.03.027; PMID: 18485877
   PubMed Web of Science ®Google Scholar
• Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12:R68; http://dx.doi.org/10.1186/bcr2635; PMID: 20813035
   PubMed Web of Science ®Google Scholar
• Bouras T, Pal B, Vaillant F, Harburg G, Asselin-Labat ML, Oakes SR, Lindeman GJ, Visvader JE. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 2008; 3:429 - 41; http://dx.doi.org/10.1016/j.stem.2008.08.001; PMID: 18940734
   PubMed Web of Science ®Google Scholar
• Buono KD, Robinson GW, Martin C, Shi S, Stanley P, Tanigaki K, Honjo T, Hennighausen L. The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy. Dev Biol 2006; 293:565 - 80; http://dx.doi.org/10.1016/j.ydbio.2006.02.043; PMID: 16581056
   PubMed Web of Science ®Google Scholar
• Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, Iscove N, Jones S, McKinney S, Emerman J, et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008; 3:109 - 18; http://dx.doi.org/10.1016/j.stem.2008.05.018; PMID: 18593563
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets 2010; 11:745 - 51; http://dx.doi.org/10.2174/138945010791170860; PMID: 20041844
   PubMed Web of Science ®Google Scholar
• Lee CW, Simin K, Liu Q, Plescia J, Guha M, Khan A, Hsieh CC, Altieri DC. A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res 2008; 10:R97; http://dx.doi.org/10.1186/bcr2200; PMID: 19025652
   PubMed Web of Science ®Google Scholar
• Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G, Egan SE. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005; 65:8530 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-05-1069; PMID: 16166334
   PubMed Web of Science ®Google Scholar
• Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O’Malley FP, Egan SE, Andrulis IL. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat 2008; 111:439 - 48; http://dx.doi.org/10.1007/s10549-007-9805-3; PMID: 17990101
   PubMed Web of Science ®Google Scholar
• Cohen B, Shimizu M, Izrailit J, Ng NF, Buchman Y, Pan JG, Dering J, Reedijk M. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. Breast Cancer Res Treat 2010; 123:113 - 24; http://dx.doi.org/10.1007/s10549-009-0621-9; PMID: 19915977
   PubMed Web of Science ®Google Scholar
• Ling H, Sylvestre JR, Jolicoeur P. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene 2010; 29:4543 - 54; http://dx.doi.org/10.1038/onc.2010.186; PMID: 20562911
   PubMed Web of Science ®Google Scholar
• Sansone P, Storci G, Giovannini C, Pandolfi S, Pianetti S, Taffurelli M, Santini D, Ceccarelli C, Chieco P, Bonafé M. p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells 2007; 25:807 - 15; http://dx.doi.org/10.1634/stemcells.2006-0442; PMID: 17158237
   PubMed Web of Science ®Google Scholar
• Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 2010; 70:709 - 18; http://dx.doi.org/10.1158/0008-5472.CAN-09-1681; PMID: 20068161
   PubMed Web of Science ®Google Scholar
• Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, Erşahin Ç, Rajan P. Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int J Surg Pathol 2012; 20:139 - 45; http://dx.doi.org/10.1177/1066896911427035; PMID: 22084425
   PubMed Web of Science ®Google Scholar
• Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, Ateeq B, Asangani IA, Iyer M, Maher CA, Grasso CS, et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 2011; 17:1646 - 51; http://dx.doi.org/10.1038/nm.2580; PMID: 22101766
   PubMed Web of Science ®Google Scholar
• Haines N, Irvine KD. Glycosylation regulates Notch signalling. Nat Rev Mol Cell Biol 2003; 4:786 - 97; http://dx.doi.org/10.1038/nrm1228; PMID: 14570055
   PubMed Web of Science ®Google Scholar
• Hicks C, Johnston SH, diSibio G, Collazo A, Vogt TF, Weinmaster G. Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Nat Cell Biol 2000; 2:515 - 20; http://dx.doi.org/10.1038/35019553; PMID: 10934472
   PubMed Web of Science ®Google Scholar
• Yang LT, Nichols JT, Yao C, Manilay JO, Robey EA, Weinmaster G. Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1. Mol Biol Cell 2005; 16:927 - 42; http://dx.doi.org/10.1091/mbc.E04-07-0614; PMID: 15574878
   PubMed Web of Science ®Google Scholar
• Xu K, Usary J, Kousis PC, Prat A, Wang DY, Adams JR, Wang W, Loch AJ, Deng T, Zhao W, et al. Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell 2012; 21:626 - 41; http://dx.doi.org/10.1016/j.ccr.2012.03.041; PMID: 22624713
   PubMed Web of Science ®Google Scholar
• Graveel CR, DeGroot JD, Su Y, Koeman J, Dykema K, Leung S, Snider J, Davies SR, Swiatek PJ, Cottingham S, et al. Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer. Proc Natl Acad Sci U S A 2009; 106:12909 - 14; PMID: 19567831
   PubMed Web of Science ®Google Scholar
• Ponzo MG, Lesurf R, Petkiewicz S, O’Malley FP, Pinnaduwage D, Andrulis IL, Bull SB, Chughtai N, Zuo D, Souleimanova M, et al. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci U S A 2009; 106:12903 - 8; http://dx.doi.org/10.1073/pnas.0810402106; PMID: 19617568
   PubMed Web of Science ®Google Scholar
• Knight JF, Lesurf R, Zhao H, Pinnaduwage D, Davis RR, Saleh SM, Zuo D, Naujokas MA, Chughtai N, Herschkowitz JI, et al. Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer. Proc Natl Acad Sci U S A 2013; 110:E1301 - 10; http://dx.doi.org/10.1073/pnas.1210353110; PMID: 23509284
   PubMedGoogle Scholar
• Gastaldi S, Sassi F, Accornero P, Torti D, Galimi F, Migliardi G, Molyneux G, Perera T, Comoglio PM, Boccaccio C, et al. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. Oncogene 2013; 32:1428 - 40; http://dx.doi.org/10.1038/onc.2012.154; PMID: 22562252
   PubMed Web of Science ®Google Scholar
• Shibue T, Brooks MW, Weinberg RA. An integrin-linked machinery of cytoskeletal regulation that enables experimental tumor initiation and metastatic colonization. Cancer Cell 2013; 24:481 - 98; http://dx.doi.org/10.1016/j.ccr.2013.08.012; PMID: 24035453
   PubMed Web of Science ®Google Scholar
• Rakha EA, Chan S. Metastatic triple-negative breast cancer. Clin Oncol (R Coll Radiol) 2011; 23:587 - 600; http://dx.doi.org/10.1016/j.clon.2011.03.013; PMID: 21524569
   PubMed Web of Science ®Google Scholar
• Stella MC, Trusolino L, Pennacchietti S, Comoglio PM. Negative feedback regulation of Met-dependent invasive growth by Notch. Mol Cell Biol 2005; 25:3982 - 96; http://dx.doi.org/10.1128/MCB.25.10.3982-3996.2005; PMID: 15870272
   PubMed Web of Science ®Google Scholar
• Zhang S, Loch AJ, Radtke F, Egan SE, Xu K. Jagged1 is the major regulator of Notch-dependent cell fate in proximal airways. Dev Dyn 2013; 242:678 - 86; http://dx.doi.org/10.1002/dvdy.23965; PMID: 23526493
   PubMed Web of Science ®Google Scholar
• Smolen GA, Muir B, Mohapatra G, Barmettler A, Kim WJ, Rivera MN, Haserlat SM, Okimoto RA, Kwak E, Dahiya S, et al. Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis. Cancer Res 2006; 66:3452 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-05-4181; PMID: 16585167
   PubMed Web of Science ®Google Scholar